BIOMAT Database Logo BIOMAT Database Logo

[The surface markers of non-Hodgkin's disease cells; classification of T and B cell lymphoma and their prognosis]. 1985

M Shimoyama, and K Minato, and S Seki, and M Nagai, and W Tatewaki, and S Watanabe

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

M Shimoyama, and K Minato, and S Seki, and M Nagai, and W Tatewaki, and S Watanabe
T-cell-rich B-cell non-Hodgkin's lymphoma mimicking Hodgkin's disease.
April 1999, Leukemia & lymphoma,
M Shimoyama, and K Minato, and S Seki, and M Nagai, and W Tatewaki, and S Watanabe
[Surface markers of the lymphoid cells in non-Hodgkin's lymphoma].
January 1980, Acta haematologica Polonica,
M Shimoyama, and K Minato, and S Seki, and M Nagai, and W Tatewaki, and S Watanabe
Phenotypic abnormality of T cells in B cell non-Hodgkin's lymphoma.
January 1990, Disease markers,
M Shimoyama, and K Minato, and S Seki, and M Nagai, and W Tatewaki, and S Watanabe
Aggressive non-Hodgkin's lymphoma: T-cell versus B-cell.
March 1996, Hematological oncology,
M Shimoyama, and K Minato, and S Seki, and M Nagai, and W Tatewaki, and S Watanabe
Clinical significance of T-regulatory cells in B-cell non-Hodgkin's lymphoma.
January 2011, The Egyptian journal of immunology,
M Shimoyama, and K Minato, and S Seki, and M Nagai, and W Tatewaki, and S Watanabe
Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease.
September 1991, Histopathology,
M Shimoyama, and K Minato, and S Seki, and M Nagai, and W Tatewaki, and S Watanabe
T-cell rich b-cell non-hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease.
January 1996, Histopathology,
M Shimoyama, and K Minato, and S Seki, and M Nagai, and W Tatewaki, and S Watanabe
T-cell rich B-cell non-Hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance Hodgkin's disease.
September 1996, Histopathology,
M Shimoyama, and K Minato, and S Seki, and M Nagai, and W Tatewaki, and S Watanabe
[Non-Hodgkin's B-cell lymphoma resembling Hodgkin's lymphoma].
December 1994, Ceskoslovenska patologie,
M Shimoyama, and K Minato, and S Seki, and M Nagai, and W Tatewaki, and S Watanabe
Importance of cell surface marker to the prognosis of non-Hodgkin's lymphoma.
October 1988, Acta medica Okayama,
Copied contents to your clipboard!